Cargando…
Mitochondrial pyruvate carrier 1 expression controls cancer epithelial‐mesenchymal transition and radioresistance
Mitochondrial pyruvate carrier (MPC) is known to cause different expressions in normal and cancer cells. We observed a change in phenotype with the suppression of MPC expression. We knocked down MPC1 and/or MPC2 using siRNA or shRNA. We observed its cell morphology and accompanying molecular marker....
Autores principales: | Takaoka, Yuji, Konno, Masamitsu, Koseki, Jun, Colvin, Hugh, Asai, Ayumu, Tamari, Keisuke, Satoh, Taroh, Mori, Masaki, Doki, Yuichiro, Ogawa, Kazuhiko, Ishii, Hideshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447954/ https://www.ncbi.nlm.nih.gov/pubmed/30801869 http://dx.doi.org/10.1111/cas.13980 |
Ejemplares similares
-
Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis
por: Koseki, Jun, et al.
Publicado: (2018) -
Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018) -
Polyamine flux suppresses histone lysine demethylases and enhances ID1 expression in cancer stem cells
por: Tamari, Keisuke, et al.
Publicado: (2018) -
Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
por: Colvin, Hugh, et al.
Publicado: (2016) -
Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells
por: Konno, Masamitsu, et al.
Publicado: (2018)